Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vickery

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Receptors & Channels|February 11, 2004
Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPRR G Vickery, S M Amagasu, R Chang, et al.
Molecular Pharmacology|December 13, 2005
Evidence for a multivalent interaction of symmetrical, N-linked, lidocaine dimers with voltage-gated Na+ channelsJ A M Smith, S M Amagasu, J Hembrador, et al.
Frontiers in Pharmacology|June 21, 2011
The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic PropertiesDavid T Beattie, Scott R Armstrong, Ross G Vickery, et al.
British Journal of Pharmacology|October 7, 2004
The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivoD T Beattie, J A M Smith, D Marquess, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749Daniel D Long, Scott R Armstrong, David T Beattie, et al.
Journal of Medicinal Chemistry|August 12, 2009
A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonistsR Murray McKinnell, Scott R Armstrong, David T Beattie, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor AntagonistDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipationDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Receptors & Channels|February 11, 2004
Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPRR G Vickery, S M Amagasu, R Chang, et al.
Molecular Pharmacology|December 13, 2005
Evidence for a multivalent interaction of symmetrical, N-linked, lidocaine dimers with voltage-gated Na+ channelsJ A M Smith, S M Amagasu, J Hembrador, et al.
Frontiers in Pharmacology|June 21, 2011
The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic PropertiesDavid T Beattie, Scott R Armstrong, Ross G Vickery, et al.
British Journal of Pharmacology|October 7, 2004
The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivoD T Beattie, J A M Smith, D Marquess, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749Daniel D Long, Scott R Armstrong, David T Beattie, et al.
Journal of Medicinal Chemistry|August 12, 2009
A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonistsR Murray McKinnell, Scott R Armstrong, David T Beattie, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor AntagonistDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipationDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Pageof 3